{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T11:10:01Z","timestamp":1749121801406,"version":"3.41.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1023\/a:1021792125123","type":"journal-article","created":{"date-parts":[[2003,3,21]],"date-time":"2003-03-21T02:15:11Z","timestamp":1048212911000},"page":"82-90","source":"Crossref","is-referenced-by-count":7,"title":["Low Molecular Weight Heparin in Immunological Recurrent Abortion\u2014The Incredible Cure"],"prefix":"10.1007","volume":"20","author":[{"given":"Gautam N.","family":"Allahbadia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swati G.","family":"Allahbadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"454567_CR1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0015-0282(16)46579-9","volume":"38","author":"DK Edmonds","year":"1982","unstructured":"Edmonds DK, Lindsay KI, Miller JF: Early embryonic mortality in women. Fertil Steril 1982;38:447\u2013453","journal-title":"Fertil Steril"},{"key":"454567_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-4471-1658-5_2","volume-title":"Early Pregnancy Loss: Mechanisms and Treatment","author":"E Alberman","year":"1988","unstructured":"Alberman E: The epidemiology of repeated abortion. In Early Pregnancy Loss: Mechanisms and Treatment, F Sharp, RW Beard (eds), New York, Springer, 1988, pp 9\u201317"},{"key":"454567_CR3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0002-9378(84)80164-7","volume":"148","author":"B Stray-Pederson","year":"1984","unstructured":"Stray-Pederson B, Stray-Pederson S: Etiological factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984;148:140\u2013146","journal-title":"Am J Obstet Gynecol"},{"key":"454567_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0897.1990.tb01023.x","volume":"22","author":"JA Hill","year":"1990","unstructured":"Hill JA: Immunological mechanisms of pregnancy maintenance and failure: A critique of theories and therapy. Am J Reprod Immunol 1990;22:1\u201312","journal-title":"Am J Reprod Immunol"},{"key":"454567_CR5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.7326\/0003-4819-92-2-156","volume":"92","author":"JR Mueh","year":"1980","unstructured":"Mueh JR, Herbst KD, Rapaport SI: Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 1980;92:156\u2013159","journal-title":"Ann Intern Med"},{"key":"454567_CR6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ajh.2830190308","volume":"19","author":"DA Gastineau","year":"1985","unstructured":"Gastineau DA, Keizmer FS, Nichols WL: Lupus anticoagulant: An analysis of the clinical and Laboratory features of 219 cases. Am J Hematol 1985;19:265\u2013275","journal-title":"Am J Hematol"},{"key":"454567_CR7","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1001\/archinte.1986.00360230069012","volume":"146","author":"EN Harris","year":"1986","unstructured":"Harris EN, Chan JKH, Asherson RA: Thrombosis, recurrent fetal loss and thrombocytopenia: Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986;146:2153\u20132159","journal-title":"Arch Intern Med"},{"key":"454567_CR8","unstructured":"Cowchock FS: The role of antiphospholipid antibodies in obstetric medicine. In Current Obstetric Medicine, RV Lee (ed), Mosby-Yearbook, St Louis, MO, pp 229\u2013247"},{"key":"454567_CR9","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0140-6736(86)90252-7","volume":"ii","author":"C Lockwood","year":"1986","unstructured":"Lockwood C, Reece LA, Roniero LT, Hobbins JC: Antiphospholipid antibody and pregnancy wastage. Lancet 1986;ii: 742\u2013743","journal-title":"Lancet"},{"key":"454567_CR10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/08916939308993318","volume":"16","author":"N Gleicher","year":"1993","unstructured":"Gleicher N, Pratt D, Dudkiewicz A: What do we really know about autoantibody abnormalities and reproductive failure: A critical review. Autoimmunity 1993;16:115\u2013140","journal-title":"Autoimmunity"},{"key":"454567_CR11","first-page":"101","volume":"10","author":"RS Rai","year":"1995","unstructured":"Rai RS, Regan L, Clifford K, Pickering W, Dave M, Mackie I: Antiphospholipid antibodies and \u03b2-2 glycoprotein-I in 500 women with recurrent miscarriage: Results of a comprehensive screening approach. Hum Reprod 1995;10:101\u2013105","journal-title":"Hum Reprod"},{"key":"454567_CR12","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1093\/oxfordjournals.humrep.a019095","volume":"11","author":"J Balasch","year":"1996","unstructured":"Balasch J, Creus M, F\u00e1brogues F: Antiphospholipid antibodies and human reproductive failure. Hum Reprod 1996;11:2310\u20132315","journal-title":"Hum Reprod"},{"key":"454567_CR13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-0378(97)00027-2","volume":"34","author":"HH Hatasaka","year":"1997","unstructured":"Hatasaka HH, Branch DW, Kutteh W, Scott JR: Autoantibody screening for infertility: Explaining the unexplained? J Reprod Immunol 1997;34:137\u2013153","journal-title":"J Reprod Immunol"},{"key":"454567_CR14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/096120339400300512","volume":"3","author":"J Balasch","year":"1994","unstructured":"Balasch J, Font J: Antiphospholipid antibody testing in patients with pregnancy loss. Lupus 1994;3:429\u2013431","journal-title":"Lupus"},{"key":"454567_CR15","first-page":"117","volume-title":"Progress in Reproductive Medicine","author":"J Balasch","year":"1995","unstructured":"Balasch J: Immunological factors in pregnancy wastage: Truth or fiction. In Progress in Reproductive Medicine, Vol 2, R Asch, JWW Studd (eds), London, Parthenon, 1995, pp 117\u2013138"},{"key":"454567_CR16","first-page":"27","volume":"11","author":"RS Rai","year":"1996","unstructured":"Rai RS, Cohen H, Regan L: Non-pregnant women with a history of recurrent miscarriage are in a pro-thrombotic state. Hum Reprod 1996;11:27\u201329","journal-title":"Hum Reprod"},{"key":"454567_CR17","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/humrep\/12.3.464","volume":"12","author":"IA Panton","year":"1997","unstructured":"Panton IA, Kilpatrick DC: Anti-cardiolipin antibodies in sexual partners of recurrent aborters. Hum Reprod 1997;12:464\u2013467","journal-title":"Hum Reprod"},{"key":"454567_CR18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0015-0282(16)60363-1","volume":"50","author":"A El-Roeiy","year":"1988","unstructured":"El-Roeiy A, Dmowski WP, Gleicher N: Danazol but not gonadotrophin-releasing hormone agonists suppress autoantibodies in endometriosis. Fertil Steril 1988;50:864\u2013871","journal-title":"Fertil Steril"},{"key":"454567_CR19","first-page":"596","volume":"77","author":"A E1-Roeiy","year":"1988","unstructured":"E1-Roeiy A, Gleicher N: Definition of normal autoantibody levels in an apparently healthy population. Obstet Gynecol 1988;77:596\u2013602","journal-title":"Obstet Gynecol"},{"key":"454567_CR20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0002-9378(93)90150-H","volume":"169","author":"C Ober","year":"1993","unstructured":"Ober C, Kamson T, Harcowe L: Autoantibodies and pregnancy history in a healthy population. Am J Obstet Gynecol 1993;169:143\u2013147","journal-title":"Am J Obstet Gynecol"},{"key":"454567_CR21","first-page":"178","volume":"i","author":"R Moulias","year":"1984","unstructured":"Moulias R, Proust J, Wanga A: Age related increase in autoantibodies. Lancet 1984;i:178\u20131129","journal-title":"Lancet"},{"key":"454567_CR22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/art.1780300207","volume":"30","author":"Y Shoenfeld","year":"1987","unstructured":"Shoenfeld Y, Segol G, Segol D: Detection of antibodies to total bistones and their subfraction in systemic lupus erythematosus patients and their asymptomatic relatives. Arthritis Rheumatica 1987;30:169\u2013175","journal-title":"Arthritis Rheumatica"},{"key":"454567_CR23","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0002-9378(94)70110-5","volume":"170","author":"N Gleicher","year":"1994","unstructured":"Gleicher N, Luih C, Dudkiewicz A: Autoantibody profiles and immunoglobulin levels as predictors of in vitro fertilization success. Am J Obstet Gynecol 1994;170:1145\u20131149","journal-title":"Am J Obstet Gynecol"},{"key":"454567_CR24","first-page":"163","volume":"70","author":"A El-Roeiy","year":"1987","unstructured":"El-Roeiy A, Gleicher N, Fribert T: Correlation between peripheral blood and follicular fluid autoantibodies and impact on in vitro fertilization. Obstet Gynecol 1987;70:163\u2013170","journal-title":"Obstet Gynecol"},{"key":"454567_CR25","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/0002-9378(89)90858-2","volume":"160","author":"N Gleicher","year":"1989","unstructured":"Gleicher N, El-Roeiy A, Carfino E, Fnberg J: Reproductive failure because of autoantibodies: Unexplained infertility and pregnancy wastage. Am J Obstet. Gynecol 1989;160:1376\u20131380","journal-title":"Am J Obstet. Gynecol"},{"key":"454567_CR26","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0015-0282(16)57008-3","volume":"62","author":"F Geva","year":"1994","unstructured":"Geva F, Yaron V, Lessing JB: Circulatory autoimmune antibodies may be responsible for implantation failure in in-vitro fertilization. Fertil Steril 1994;62:802\u2013806","journal-title":"Fertil Steril"},{"key":"454567_CR27","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/0002-9378(91)90695-N","volume":"164","author":"A El-Roeiy","year":"1991","unstructured":"El-Roeiy A, Myers SA, Gleicher N: The relationship between autoantibodies and intrauterine growth retardation in hypertensive disorders of pregnancy. Am J Obstet Gynecol 1991;164:1253\u20131261","journal-title":"Am J Obstet Gynecol"},{"key":"454567_CR28","first-page":"231","volume":"28","author":"T Kajino","year":"1991","unstructured":"Kajino T: Polyclonal activation of 1gM antibodies to phospholipids in patients with idiopathic growth retardation. Am J Reprod. Immunol 1991;28:231\u2013234","journal-title":"Am J Reprod. Immunol"},{"key":"454567_CR29","first-page":"1108","volume":"78","author":"WJ Polzin","year":"1991","unstructured":"Polzin WJ, Kopelman JN, Robinson RD: The association of antiphospholipid antibodies with pregnancies complicated by fetal growth retardation. Obstet Gynecol 1991;78:1108\u20131111","journal-title":"Obstet Gynecol"},{"key":"454567_CR30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9378(11)91619-6","volume":"167","author":"HJ Out","year":"1992","unstructured":"Out HJ, Bruinse HW, Christiaens GCML. A prospective, controlled multicenter study on obstetric risk of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 1992;167:26\u201332","journal-title":"Am J Obstet Gynecol"},{"key":"454567_CR31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0029-7844(95)00247-O","volume":"86","author":"M Yasuda","year":"1995","unstructured":"Yasuda M, Takakuwa K, Tokunaga A, Tanaka K: Prospective studies of th association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995;86:555\u2013559","journal-title":"Obstet Gynecol"},{"key":"454567_CR32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJM198507183130304","volume":"313","author":"RD Lockshin","year":"1985","unstructured":"Lockshin RD, Druzin ML, Goei S: Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985;313:152\u2013156","journal-title":"N Engl J Med"},{"key":"454567_CR33","first-page":"773","volume":"167","author":"SL Tan","year":"1992","unstructured":"Tan SL, Doyle P, Campbell S: Obstetric outcome of in vitro fertilization pregnancies compared with normally conceived pregnancies. Am J Obstet Gynecol 1992;167:773\u2013784","journal-title":"Am J Obstet Gynecol"},{"key":"454567_CR34","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0015-0282(16)56526-1","volume":"61","author":"P Nurat","year":"1994","unstructured":"Nurat P, Olivennes F, de Muzon J: Task force report on the outcome of pregnancies and children conceived by in vitro fertilization (France: 1987 to 1989). Fertil Steril 1994;61:324\u2013330","journal-title":"Fertil Steril"},{"key":"454567_CR35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0015-0282(16)58395-2","volume":"66","author":"F Olivennes","year":"1996","unstructured":"Olivennes F, Kadhel P, Rufat P: Perinatal outcome of twin pregnancies obtained after in vitro fertilization: Comparison with twin pregnancies obtained spontaneously after ovarian stimulation. Fertil Steril 1996;66:105\u2013109","journal-title":"Fertil Steril"},{"key":"454567_CR36","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ajcp\/94.4.476","volume":"94","author":"EN Harris","year":"1990","unstructured":"Harris EN: Special report. The second international anti-cardiolipin standardization workshop\/the Kingston Anti-phospholipid Antibody Study (KAPS) Group. Am J Clin Pathol 1990;94:476\u201384","journal-title":"Am J Clin Pathol"},{"key":"454567_CR37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jama.1992.03490110089036","volume":"268","author":"MD Lockshin","year":"1992","unstructured":"Lockshin MD: Antiphospholipid antibody syndrome. JAMA 1992;268:451\u20131453","journal-title":"JAMA"},{"key":"454567_CR38","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0002-9378(92)91596-3","volume":"166","author":"FS Cowchock","year":"1992","unstructured":"Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L: Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992;166:1318\u201323","journal-title":"Am J Obstet Gynecol"},{"key":"454567_CR39","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","volume":"174","author":"WH Kutteh","year":"1996","unstructured":"Kutteh WH: Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low dose aspirin is superior to low dose aspirin. Am J Obstet Gynecol 1996;174:1584\u20131589","journal-title":"Am J Obstet Gynecol"},{"key":"454567_CR40","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/oxfordjournals.humrep.a019238","volume":"11","author":"A Raziel","year":"1996","unstructured":"Raziel A, HermanA, BukovskyI: Intravenous immunoglobulin treatment of pregnant patients with unexplained recurrent abortions. Hum Reprod 1996;11:711\u2013715","journal-title":"Hum Reprod"},{"key":"454567_CR41","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.humrep.a136029","volume":"10","author":"R Bronson","year":"1995","unstructured":"Bronson R: Editorial: Immunology and reproductive medicine. Hum Reprod 1995;10:755\u2013757","journal-title":"Hum Reprod"},{"key":"454567_CR42","first-page":"614","volume":"80","author":"DW Branch","year":"1992","unstructured":"Branch DW, Silver RM, Blackwell LL: Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience. Obstet Gynecol 1992;80:614\u2013620","journal-title":"Obstet Gynecol"},{"key":"454567_CR43","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood.V84.9.2854.2854","volume":"89","author":"RA Roubey","year":"1994","unstructured":"Roubey RA: Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other phospholipid antibodies. Blood 1994;89:2854\u20132867","journal-title":"Blood"},{"key":"454567_CR44","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0002-9378(94)70110-5","volume":"170","author":"N Gleicher","year":"1994","unstructured":"Gleicher N, Liu H, Dudkiewicz A: Autoantibody profiles and immunoglobulin levels as predictors of IVF success. Am J Obstet Gynecol 1994;170:1145\u20131149","journal-title":"Am J Obstet Gynecol"},{"key":"454567_CR45","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/oxfordjournals.humrep.a019352","volume":"11","author":"MA Birdsall","year":"1996","unstructured":"Birdsall MA, Lockwood GM, Ledger WL: Antiphospholipid antibodies in women having in-vitro fertilization. Hum Reprod 1996;11:1185\u20131189","journal-title":"Hum Reprod"},{"key":"454567_CR46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0005-2736(83)90442-X","volume":"728","author":"A Sessions","year":"1982","unstructured":"Sessions A, Horowitz AF: Differentiation-related difference in the plasma membrane phospholipid asymmetry of myogenic and firbrogenic cells. Biochim Biophys Acta 1982;728:103\u2013111","journal-title":"Biochim Biophys Acta"},{"key":"454567_CR47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0897.1992.tb00753.x","volume":"28","author":"NS Rote","year":"1992","unstructured":"Rote NS, Walter A, Lyden TW: Antiphospholipid antibodies\u2013lobsters or red herrings? Am J Reprod Immunol 1992;28:31\u20137","journal-title":"Am J Reprod Immunol"},{"key":"454567_CR48","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/oxfordjournals.humrep.a138437","volume":"9","author":"G Sher","year":"1994","unstructured":"Sher G, Feinman M, Zouves C: High fecundity rates following in-vitro fertilization and embryo transfer in anti-phospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod 1994;9:2278\u20132283","journal-title":"Hum Reprod"},{"key":"454567_CR49","unstructured":"Kowalik A, Vichnin M, Branch W, Berkeley A: Mid-follicular anticardiolipin and antiphosphatidylserine antibody titers do not correlate with IVF outcome. American Society of Reproductive Medicine Meeting, November 1996, Boston, MA, USA. Abstract P-130"},{"key":"454567_CR50","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0897.1995.tb01133.x","volume":"33","author":"LD Ermel","year":"1995","unstructured":"Ermel LD, Marshbum PB, Kutteh WH: Interaction of heparin with antiphospholipid antibodies (APA) from serum of women with recurrent pregnancy loss (RPL). Am J Reprod Immunol 1995;33:14\u201320","journal-title":"Am J Reprod Immunol"},{"key":"454567_CR51","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199405053301808","volume":"330","author":"C Patrono","year":"1994","unstructured":"Patrono C: Aspirin as an antiplatelet drug. N Eng J Med 1994;330:1287\u20131294","journal-title":"N Eng J Med"},{"key":"454567_CR52","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0029-7844(95)00042-P","volume":"85","author":"JL Hauth","year":"1995","unstructured":"Hauth JL: Low-dose aspirin: Lack of association with an increase in abruptio placentae or perinatal mortality. Obstet Gynecol 1995;85:1055\u20131058","journal-title":"Obstet Gynecol"},{"key":"454567_CR53","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0090-6980(86)90042-0","volume":"32","author":"PV Malathy","year":"1986","unstructured":"Malathy PV, Cheng HC, Dey SE: Production of leukotrienes and prostaglandins in the rat uterus during preimplantation period. Prostaglandins 1986;32:605\u2013614","journal-title":"Prostaglandins"},{"key":"454567_CR54","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1095\/biolreprod30.3.544","volume":"38","author":"LH Hoffman","year":"1984","unstructured":"Hoffman LH, Davenport GR, Brash AR: Endometrial prostaglandins and phospholipase activity related to implantation in rabbits: Effects of dexamethasone. Biol Reprod 1984;38:544\u2013555","journal-title":"Biol Reprod"},{"key":"454567_CR55","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/978-1-4684-5284-6_18","volume-title":"Platelet-Activating Factor and Related Lipid Mediators","author":"JM Johnston","year":"1987","unstructured":"Johnston JM, Bleasdale JE, Hoffman DR: Functions of PAF in reproduction and development: involvement of PAF in fetal lung maturation and parturition. In Platelet-Activating Factor and Related Lipid Mediators, F Synyer (ed), New York, Plenum, 1987, p 375"},{"key":"454567_CR56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0739-7240(87)90001-4","volume":"4","author":"C O'Neill","year":"1987","unstructured":"O'Neill C: Embryo-derived platelet activating factor: A preimplantation embryo mediator of maternal recognition of pregnancy. Domest Anim Endocrinol 1987;4:69\u201385","journal-title":"Domest Anim Endocrinol"},{"key":"454567_CR57","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF01139339","volume":"2","author":"C O'Neill","year":"1985","unstructured":"O'Neill C, Gidley-Baird AA, Pike JL, Porter RN, Sinosich MJ, Saunders DM: Maternal blood platelet physiology and luteal phase endocrinology as a means of monitoring pre and postimplantation embryo viability following in vitro fertilization. J In Vitro Fertil Embryo Transfer 1985;2:87\u201393","journal-title":"J In Vitro Fertil Embryo Transfer"},{"key":"454567_CR58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0165-0378(90)90041-4","volume":"17","author":"PV Holmes","year":"1989","unstructured":"Holmes PV, Sjogren A, Hamberger L: Prostaglandin-E2 released by preimplantation human conceptuses. J Reprod Immunol 1989;17:79\u201386","journal-title":"J Reprod Immunol"},{"key":"454567_CR59","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/oxfordjournals.humrep.a137354","volume":"6","author":"RMF van der Welden","year":"1991","unstructured":"van der Welden RMF, Helmerhorst FM, Keirse MJNC: Influence of prostaglandins and platelet activating factor on implantation. Hum Reprod 1991;6:436\u2013442","journal-title":"Hum Reprod"},{"key":"454567_CR60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0014-5793(81)80554-6","volume":"34","author":"A Sessions","year":"1981","unstructured":"Sessions A, Horowitz AF: Myoblast aminophospholipid asymmetry differs from that of fibroblasts. FEBS 1981;34:75\u201378","journal-title":"FEBS"},{"key":"454567_CR61","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1073\/pnas.87.11.4112","volume":"87","author":"J Rauch","year":"1990","unstructured":"Rauch J, Janoff AS: Phospholipid in the hexagonal 11 phase is immunogenic: Evidence for immunorecognition of nonbilayer lipid phases in vivo. Proc Nazi Acad Sci USA 1990;87:4112\u20134114","journal-title":"Proc Nazi Acad Sci USA"},{"key":"454567_CR62","first-page":"734","volume":"7","author":"RH Asch","year":"1993","unstructured":"Asch RH: High pregnancy rates after oocyte and embryo donation. Hum Reprod 1993;7:734","journal-title":"Hum Reprod"},{"issue":"4","key":"454567_CR63","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0015-0282(16)54605-6","volume":"56","author":"B Fisch","year":"1991","unstructured":"Fisch B, Rikover Y, Shohat L, Zurgil N, Tadir Y, Ovadia J, Wik I, Yron I: The relationship between in vitro fertilization and naturally occurring antibodies: Evidence for increased production of antiphospholipid antibodies. Fertil Steril 1991;56(4):718\u2013724","journal-title":"Fertil Steril"},{"key":"454567_CR64","first-page":"3","volume":"35","author":"M Schwartz","year":"1991","unstructured":"Schwartz M, Jewelewicz R: The use of gonadotrophins for induction of ovulation. Fertil Steril 1991;35:3","journal-title":"Fertil Steril"},{"key":"454567_CR65","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0015-0282(16)49209-5","volume":"45","author":"AR Scialli","year":"1986","unstructured":"Scialli AR: The reproductive toxicity of ovulation induction. Fertil Steril 1986;45:315","journal-title":"Fertil Steril"},{"issue":"Suppl1","key":"454567_CR66","first-page":"202","volume":"23","author":"JA McIntyre","year":"1993","unstructured":"McIntyre JA, Taylor CG, Torry DS, Wagenknecht DR, Wilson J, Faulk WP: Heparin and pregnancy in women with a history of repeated miscarriages. Haemostasis 1993;23(Suppl 1):202\u2013211","journal-title":"Haemostasis"},{"key":"454567_CR67","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0307-742X(21)00606-8","volume":"11","author":"EN Harris","year":"1985","unstructured":"Harris EN, Gharavi AE, Hughes GRV: Antiphospholipid antibodies. Clin Rheum Dis 1985;11:591\u2013609","journal-title":"Clin Rheum Dis"},{"key":"454567_CR68","first-page":"27","volume":"39","author":"W Matzner","year":"1994","unstructured":"Matzner W, Chong F, Xu HF, Chung W: Characterization of antiphospholipid antibodies in women with recurrent spontaneous abortions. J Reprod Med 1994;39:27\u201330","journal-title":"J Reprod Med"},{"key":"454567_CR69","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0002-9378(16)32527-3","volume":"142","author":"F Jewolf","year":"1982","unstructured":"Jewolf F, Carreras LO, Moennan P: Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982;142, 829\u2013834","journal-title":"Am J Obstet Gynecol"},{"key":"454567_CR70","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0028-2243(91)90021-C","volume":"41","author":"HJ Out","year":"1991","unstructured":"Out HJ, Kooijman CD, Bruinse HW, Derksen RH: Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol Reprod Biol 1991;41:179\u2013186","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"454567_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0378(92)90002-L","volume":"22","author":"TW Lyden","year":"1992","unstructured":"Lyden TW, Vogt E, Ng AK: Monoclonal antiphospholipid antibody reactivity against human placental trophoblast. J. Reprod Immunol 1992;22:1\u201314","journal-title":"J. Reprod Immunol"},{"key":"454567_CR72","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1095\/biolreprod56.1.50","volume":"56","author":"H Katsuragawa","year":"1997","unstructured":"Katsuragawa H, Kanzaki H, Inoue T: Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion. Biol Reprod 1997;56:50\u201358","journal-title":"Biol Reprod"},{"key":"454567_CR73","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/oxfordjournals.humrep.a019125","volume":"11","author":"B Tartakovsky","year":"1996","unstructured":"Tartakovsky B, Bermas BL, Sthoeger Z: Defective maternal\u2014fetal interaction in a murine autoimmune model. Hum Reprod 1996;11:2408\u20132411","journal-title":"Hum Reprod"},{"key":"454567_CR74","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0015-0282(97)81519-1","volume":"68","author":"A Kowalik","year":"1997","unstructured":"Kowalik A, Viehnin M, Li HC, Branch W, Berkeley A: Mid-follicular anticardiolipin and antiphosphatidylserine antibody titers do not correlate with in vitro fertilization outcome. Fertil Steril 1997;68:298\u2013304","journal-title":"Fertil Steril"},{"key":"454567_CR75","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0002-9378(97)70409-5","volume":"176","author":"S Cowchock","year":"1997","unstructured":"Cowchock S, Reece EA: For the Organizing Group of the Antiphospholipid Antibody Treatment Trial. Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Am J Obstet Gynecol 1997;176:1099\u20131100","journal-title":"Am J Obstet Gynecol"},{"key":"454567_CR76","first-page":"163","volume-title":"Implantation: Biological and Clinical Aspects","author":"DA Clark","year":"1989","unstructured":"Clark DA: Current concepts of immunoregulation of implantation. In Implantation: Biological and Clinical Aspects, M Chapman, G Grudzinskas, T Chard (eds), London, Springer, 1989, pp 163\u2013175"},{"key":"454567_CR77","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0897.1994.tb00848.x","volume":"31","author":"A Birkenfeld","year":"1994","unstructured":"Birkenfeld A, Mukaida T, Minichiello L: Incidence of autoimmune antibodies in failed embryo transfer cycles. Am J Reprod Immunol 1994;31:65\u201368","journal-title":"Am J Reprod Immunol"},{"key":"454567_CR78","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1093\/oxfordjournals.humrep.a135745","volume":"10","author":"E Geva","year":"1995","unstructured":"Geva E, Amit A, Lemer-Geva L: Autoimmune disorders: Another possible cause for in-vitro fertilization and embryo transfer failure. Hum Reprod 1995;10:2560\u20132563","journal-title":"Hum Reprod"},{"key":"454567_CR79","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-0897.1996.tb00499.x","volume":"35","author":"B Kaider","year":"1996","unstructured":"Kaider B, Price DL, Rouses RG, Coulam CR: Antiphospholipid antibody prevalence in patients in an IVF program. J Reprod Immunol 1996;35:388\u2013393","journal-title":"J Reprod Immunol"},{"key":"454567_CR80","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/humrep\/12.1.197","volume":"12","author":"R Rai","year":"1997","unstructured":"Rai R, Regan L: Antiphospholipid antibodies in women undergoing in-vitro fertilization. Hum Reprod 1997;12:197\u2013198","journal-title":"Hum Reprod"},{"key":"454567_CR81","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/humrep\/14.2.489","volume":"14","author":"N Di Simone","year":"1999","unstructured":"Di Simone N, Caliandro D, Castellani R, Freazzani G, Carolis S, Caruso A. Low molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Hum Reprod 1999;14:489\u2013495","journal-title":"Hum Reprod"},{"key":"454567_CR82","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/humrep\/12.9.2061","volume":"12","author":"N Di Simone","year":"1997","unstructured":"Di Simone N, Ferrazzani S, Castellani R: Heparin and low-dose aspirin restore placental human chorionic gonadotrophin secretion abolished by antiphospholipid antibody-containing sera. Hum Reprod 1997;12:2061\u20132065","journal-title":"Hum Reprod"},{"key":"454567_CR83","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJM199707173370303","volume":"337","author":"JH Rand","year":"1997","unstructured":"Rand JH, Wu XX, Andree HAM: Pregnancy loss in the antiphospholipid antibody syndrome: A possible thrombogenic mechanism. N Engl J Med 1997;337:154\u2013160","journal-title":"N Engl J Med"},{"key":"454567_CR84","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0049-3848(92)90063-G","volume":"68","author":"JA Mcintyre","year":"1992","unstructured":"Mcintyre JA, Wagenknecht DR: Interaction of heparin with beta2-glycoprotein I and antiphospholipid antibodies in vitro. Thromb Res 1992;68:495\u2013500","journal-title":"Thromb Res"},{"key":"454567_CR85","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-0897.1996.tb00501.x","volume":"35","author":"WH Kutteh","year":"1996","unstructured":"Kutteh WH, Ermel LD: A clinical trial for the treatment of aPL associated RPL with lower dose heparin and aspirin. Am J Reprod Immunol 1996;35:402\u2013407","journal-title":"Am J Reprod Immunol"},{"key":"454567_CR86","first-page":"116","volume":"16","author":"J Dawes","year":"1986","unstructured":"Dawes J, Bara L, Billaud E. Relationship between biological activity and concentration of a low molecular-weight heparin (PK 10169) and unfractionated heparin after intravenous and subcutaneous administration. Haemostasis 1986;16:116\u2013122","journal-title":"Haemostasis"},{"key":"454567_CR87","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0029-7844(95)00452-1","volume":"87","author":"M Dulitzki","year":"1996","unstructured":"Dulitzki M, Pauzner R, Langevitz P: Low molecular weight heparin during pregnancy and delivery: Preliminary experience with 41 pregnancies. Obstet Gynecol 1996;87:380\u2013383","journal-title":"Obstet Gynecol"},{"key":"454567_CR88","doi-asserted-by":"crossref","first-page":"305S","DOI":"10.1378\/chest.108.4_Supplement.305S","volume":"108","author":"JS Ginsberg","year":"1995","unstructured":"Ginsberg JS, Hirsch J: Use of antithrombotic agents during pregnancy. Chest 1995;108:305S-311S","journal-title":"Chest"},{"key":"454567_CR89","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0049-3848(85)90244-0","volume":"39","author":"L Bara","year":"1985","unstructured":"Bara L, Billaud E, Garamond G, Kher H: Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration. Thromb Res 1985;39:631\u2013636","journal-title":"Thromb Res"},{"key":"454567_CR90","first-page":"65","volume":"543","author":"L Bara","year":"1988","unstructured":"Bara L, Samana M: Pharmacokinetics of low molecular weight heparins. Acta Chir Scand Suppl 1988;543:65\u201372","journal-title":"Acta Chir Scand Suppl"},{"key":"454567_CR91","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0038-1642376","volume":"71","author":"M Monreal","year":"1994","unstructured":"Monreal M, Lafoz E, Olive A: Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (fragmin) in patients with venous thromboembolism and contraindications to Coumarin. Thromb Hemost 1994;71:7\u201311","journal-title":"Thromb Hemost"},{"key":"454567_CR92","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0301-2115(95)02358-5","volume":"65","author":"J Shefras","year":"1996","unstructured":"Shefras J, Farquarson RG: Bone density studies in pregnant women receiving heparin. Eur J Obstet Gynecol Reprod Biol 1996;65:171\u2013174","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"454567_CR93","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0038-1651102","volume":"57","author":"F Forestier","year":"1987","unstructured":"Forestier F, Daffos F, Rainaut M, Toulemonde F: Low molecular weight heparin (Cy216) does not cross the placenta during the third trimester of pregnancy. Thromb Hemost 1987;57:234\u2013239","journal-title":"Thromb Hemost"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1021792125123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1021792125123\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1021792125123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T10:57:46Z","timestamp":1749121066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1021792125123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["454567"],"URL":"https:\/\/doi.org\/10.1023\/a:1021792125123","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"type":"print","value":"1058-0468"},{"type":"electronic","value":"1573-7330"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}